XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (24,367) $ (199,065)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, depletion and amortization 105,592 108,746
Amortization of debt issuance costs 3,839 3,990
Impairment of oil and gas properties 0 289,085
Stock-based compensation expense 10,219 11,397
Deferred income taxes (1,231) (702)
(Decrease) increase in allowance for doubtful accounts (500) 1,112
Other operating expenses 3,988 2,145
Derivative activities:    
Total losses (gains) 85,672 (160,222)
Cash settlements on derivatives (54,204) 106,975
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable (16,760) 21,985
(Increase) decrease in other assets (19,062) (919)
(Decrease) increase in accounts payable and accrued expenses (11,343) (29,882)
Increase (Decrease) in other liabilities 415 (10,226)
Net cash provided by operating activities 82,258 144,419
Capital expenditures:    
Capital expenditures (105,046) (62,321)
Changes in capital expenditures accruals 5,299 (10,347)
Acquisition of properties and equipment and other (11,649) (2,104)
Proceeds from sale of property and equipment and other 860 250
Net cash used in investing activities (110,536) (74,522)
Cash flows from financing activities:    
Borrowings under 2017 RBL credit facility 0 228,900
Repayments on 2017 RBL credit facility 0 (230,750)
Dividends paid on common stock (6,686) (19,447)
Purchase of treasury stock (2,440) 0
Shares withheld for payment of taxes on equity awards and other (1,543) (980)
Debt issuance costs (3,449) 0
Net cash used in financing activities (14,118) (22,277)
Net (decrease) increase in cash and cash equivalents (42,396) 47,620
Cash and cash equivalents:    
Beginning 80,557 0
Ending $ 38,161 $ 47,620